Drug profile · INN
clocortolone pivalate
CLODERM
clocortolone pivalate (CLODERM) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Drug details — clocortolone pivalate
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
clocortolone pivalate (CLODERM) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
Key facts
Mechanism of action
Glucocorticoid receptor agonist
Primary target: Glucocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is clocortolone pivalate?
clocortolone pivalate (CLODERM) is a glucocorticoid receptor agonist. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for clocortolone pivalate?
CLODERM is a marketed brand name for clocortolone pivalate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clocortolone pivalate?
clocortolone pivalate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.